Phase I/II Trial of Early Infusion of Rapidly-generated Multivirus Specific T Cells (MVST) to Prevent Post Transplant Viral Infections

NCT02231853 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

12

Enrollment

NIH

Sponsor class

Conditions

Chronic Lymphocytic Leukemia
CML (Chronic Myelogenous Leukemia)
MDS (Myelodysplastic Syndrome)
Acute Lymphoblastic Leukemia
AML (Acute Myelogenous Leukemia)

Interventions

BIOLOGICAL: MVST
BIOLOGICAL: MVSTr

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)